The next-generation sequencing (NGS) data analysis market is projected to reach $4.21b by 2032 at a compound annual growth rate of approximately 20%, according to SNS Insider pvt ltd.

An overview of bioinformatics and where it fits into NGS workflows–including target enrichment; A walk-through of the analysis stages of Roche’s bioinformatics container solution for target-enriched ...

But, as with any great methodology shift, several challenges impede its widespread implementation. From cancer complexities such as tumor heterogeneity to bottlenecks in next-generation sequencing ...

Collaboration integrates DNAnexus’ proven biomedical data analysis platform with Twist’s NGS Methylation Detection and Unique Molecular Identifier Adapter Systems MOUNTAIN VIEW, Calif. & SOUTH ...

Abstract Although a common cause of disease, copy number variants (CNVs) have not routinely been identified from next-generation sequencing (NGS) data in a clinical context.

Next-generation sequencing (NGS) has revolutionized oncology diagnostics. However, the interpretation of complex genomic data has become a critical bottleneck in clinical workflows. Manual data ...